Zach Lahn and the FirmTech Contradiction: A Political and Corporate Scrutiny

The intersection of private equity, medical technology, and political ambition has placed Iowa Republican gubernatorial candidate Zach Lahn at the center of a burgeoning controversy regarding his financial ties to FirmTech, a company specializing in male sexual health hardware. As Lahn prepares for a high-stakes general election contest against Democratic state auditor Rob Sand, his past role as a board member and major shareholder of FirmTech has drawn intense scrutiny. At the heart of the dispute is a fundamental disagreement over product classification: while Lahn characterizes his investment as a contribution to a serious "grade two medical device" enterprise, a review of historical corporate marketing and internal documents reveals a company that has long embraced the "sex toy" label to drive consumer interest.

A Chronology of Investment and Corporate Oversight

The financial relationship between Lahn and FirmTech began in 2020, when he joined the company’s board of directors. The involvement deepened in September 2021, when Lahn, acting through his wholly owned investment vehicle, the Selah Group LLC, contributed $1 million in capital. This transaction secured him 1,250 shares, establishing him as the firm’s second-largest shareholder with a 28.2 percent equity stake.

During his tenure on the board, which lasted until September 2023, the company marketed its primary offerings—including the Tech Ring and the MaxPR—to a consumer base that often viewed them through the lens of sexual wellness and pleasure. Lahn’s campaign asserts that his departure from the board was prompted by "concerns about the company’s marketing and direction." Furthermore, the campaign maintains that Lahn exited the firm prior to the release of any products explicitly branded for "pleasure," a claim that has been challenged by recent investigative reporting.

The Marketing Disconnect: Medical Device vs. Sex Toy

The primary tension in this narrative lies in the gap between Lahn’s current political framing and the company’s historical digital footprint. Digital archives from the FirmTech website provide a clear record of the firm’s positioning. A June 2022 blog post, published while Lahn served on the board, explicitly categorized the company’s products: "Cock rings are sex toys which are worn by men and people with penises."

This nomenclature was not limited to early-stage marketing. In January 2023, the company issued a press release celebrating an award from XBIZ—a trade organization for the adult industry—which honored the Tech Ring as the "Most Innovative Sex Toy of the Year." Subsequent content from June 2023, titled "2023 Sex Toy Trends," explicitly described the Tech Ring as "not only a sex-enhancing toy that prolongs erections, but also a valuable personal wellness tool."

While many of these specific posts have been removed or redirected, the persistence of the terminology is notable. As of June 2026, long after Lahn’s departure, marketing copy for the Max Performance Ring continued to describe the device as the "go-to male sex toy for enhancing sexual performance."

The Legal and Regulatory Stance of FirmTech

FirmTech’s leadership has moved aggressively to distance the brand from the "sex toy" classification, viewing the term as a potential threat to its clinical legitimacy. Dr. Elliot Justin, co-founder and CEO of FirmTech, has been vocal in his opposition to the label, arguing that it creates a barrier between the user and necessary medical intervention.

"Calling our products ‘toys’ is inaccurate and shallow," Justin stated in a recent interview. "If you claim that we are a ‘sex toy’ company, we will seek correction and if necessary take legal action."

From a clinical perspective, the company’s core technology—specifically the sensor-enabled Tech Ring—is designed to monitor nocturnal erections, providing data that can assist urologists in diagnosing erectile dysfunction (ED). The medical argument, supported by co-founder Dr. James Hotaling, suggests that the "sex toy" stigma marginalizes a legitimate tool for men’s health. However, the legal threat issued by the company’s general counsel toward publications that categorize their products as toys highlights the company’s struggle to bridge the divide between medical device manufacturing and the adult consumer goods market.

Political Implications and the Question of Transparency

For a candidate like Lahn, the controversy is less about the efficacy of the devices and more about the transparency of his professional history. The broader question posed by political analysts and opponents is whether Lahn has been forthcoming with Iowa voters regarding his business background.

The political environment in the United States, and increasingly in other Western nations, remains polarized regarding the intersection of sex education, sexual health, and public policy. The recent discourse in the United Kingdom, where political figures have debated the appropriateness of displaying sex education aids in Parliament, underscores the potential for this topic to become a cultural lightning rod. When Conservative leader Kemi Badenoch criticized the display of such items as "fiddling while Rome burns," she illustrated how quickly discourse surrounding sexual health can be weaponized in a political setting.

Lahn’s attempt to reframe his investment as purely medical—a "grade two medical device" venture—is an effort to neutralize potential criticism from conservative voters who may be wary of the adult industry. However, the ease with which his critics have utilized archived company records suggests that this defensive strategy faces significant headwinds.

The Evolution of the "Sextech" Sector

The "sextech" industry has spent the last decade attempting to shift the public perception of its products from novelty items to wellness tools. This shift is grounded in data; the global sexual wellness market is projected to reach tens of billions in valuation by the end of the decade, driven by increased health awareness and technological integration.

Companies like FirmTech sit at a unique intersection. They produce hardware that collects objective biometric data, which can objectively be classified as medical in nature. Yet, these devices are sold in a marketplace dominated by consumer pleasure products. The reality of the modern retail environment is that products can hold dual identities. A device that helps a man manage erectile dysfunction is simultaneously a "sex toy" in the eyes of the consumer, the retailer, and the award-granting bodies like XBIZ.

Conclusion: The Challenge of Narrative Control

As the November 3 election approaches, Zach Lahn’s campaign will likely continue to face questions about his role in the development and marketing of these products. The core issue for voters is not the nature of the product itself, but the consistency of the candidate’s message.

In public office, the ability to navigate complex, often uncomfortable, policy areas is a prerequisite for leadership. Whether Lahn can successfully separate his past private sector ventures from his public-facing platform remains to be seen. What is clear, however, is that in an era of permanent digital record-keeping, the attempt to redefine a product’s identity post-facto is a formidable challenge. The archives of FirmTech’s blog will remain a permanent fixture in the campaign narrative, ensuring that the debate over what constitutes a "medical device" versus a "sex toy" will continue to color the gubernatorial race in Iowa until the final ballots are cast.